Business Context and Reporting Period
This Form 6-K filing by Nanobiotix S.A. covers the reporting period of April 10, 2025. The document serves as a notification of transactions by Persons Discharging Managerial Responsibilities (PDMR) and persons closely associated with them, filed in compliance with the EU Market Abuse Regulation (MAR).
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is strictly a regulatory disclosure regarding insider transactions and does not contain financial performance data.
Material Changes
No material changes to financial performance or operations are reported in this document. The filing solely discloses the occurrence of PDMR transactions as required by law.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, risk factors, or discussion of unusual items. The content is limited to the attachment of PDMR notifications (Exhibit 99.1).
Key Facts for Investor Verification
- The filing discloses insider transactions by PDMR and associated persons as of April 10, 2025.
- Specific details of the transactions are contained in Exhibit 99.1, which is a translation of the French version.
- The report was signed by Bart Van Rhijn, Chief Financial and Business Officer.
- No financial results or operational updates are included in this specific Form 6-K.